These RNA and DNA jabs, as they are more accurately called, are being administered both to people and animals in the modern age. And the RNA and DNA residues that end up making their way into the foods that people eat is perhaps more serious of a threat to public health than anything else currently in circulation.

The World Health Organization (WHO) created a “DNA vaccines” information page on its website that explains in further detail how these injections work. One noteworthy passage reads as follows:

“The field of DNA vaccination is developing rapidly. Vaccines currently being developed use not only DNA, but also include adjuncts that assist DNA to enter cells, target it towards specific cells, or that may act as adjuvants in stimulating or directing the immune response.”

This is a terrifying revelation in that it shows how DNA vaccines as defined by official public health sources are a Trojan Horse that delivers foreign lab-made DNA into cell nuclei, possibly permanently.

A research paper discussing all this explains that there are several bacterial species in existence that are capable of transferring vaccine plasmids to mammalian host cells. These bacterial species are basically cell factories capable of producing a very large number of DNA plasmids.

The paper further highlights a discovery made by Walter Shaffner in 1980 showing for the first time the occurrence of gene transfer from bacteria to mammalian cells “when tandem copies of the SV40 virus genome, carried by E. coli laboratory strains, were transferred into co-cultured mammalian cells.”

“Bacterial DNA vaccine delivery systems consist in the internalization of bacteria, harboring a plasmid vector containing the sequence of the gene of interest, by target cells,” the paper explains.

“Subsequently primary vesicle are formed and then fused to lysosomal compartments where lysis of bacteria occurs, releasing the plasmid DNA into the host’s cytosol. The plasmid DNA then migrates to the nucleus of the cell where the gene sequence of interest is transcribed for subsequent transduction and protein synthesis by the host’s cells machinery.”

(Related: Scientists from MIT found that RNA vaccines can be absorbed through the stomach and intestines, so what does this mean for people who eat meat from animals given RNA jabs?)

Loophole allows organic foods to contain altered DNA

In much simpler terms, DNA vaccines are designed in such a way as to allow pharmaceutical companies to deliver whatever chemical payload they wish using SV40 and other adjuvant constituents. Worse yet, that payload may be self-replicating, taking over a person’s genome forever.

One of the reasons why Pfizer-BioNTech and Moderna are lying about their “mRNA” jabs being RNA-based rather than DNA-based is because DNA vaccines are much more of a threat to the body.

“If RNA vaccines and treatments are scary, DNA based gene therapies are an absolute nightmare,” writes attorney Thomas Renz on his Substack.

“… there are billions of line[s] of code that make up the human genome and we cannot even write a few million in an operating system or phone without bugs so why … would I want someone tinkering with the code that makes me live?”

This rapidly advancing field of gene therapy – these are not just simple vaccines – involves two major components: one being the genetic code to rewrite cells and the other being the vehicle, or adjuvant, used to deliver the new code into the cells. SV40, which causes cancer, is one such adjuvant used in COVID jabs that renders them wildly unsafe.

“When the jabs themselves are being made they are essentially distilled from DNA particles down into the ‘mRNA’ that is in the shots,” Renz writes. “It appears that the DNA used to create these mRNA particles is SV40. I say this because we keep finding SV40 in the vials and also because it is a natural fit for the job.”

If Big Pharma so easily lied about these shots being mRNA when the reality is that they are actually modRNA, it is not wild speculation to assume that the pharmaceutical industry also intentionally allowed modified SV40 DNA to also exist inside COVID jab vials, despite not being labeled and approved as such.

Concerning the food supply, there are a number of DNA vaccines for animals that are already being injected into cows, chickens, pigs and other animals consumed by humans. Based on what we now know concerning the negative effects of these DNA vaccines once inside their mammalian hosts, it only makes sense that humans are effectively eating modRNA, including DNA and RNA fragments, in meat.

Choosing only certified organic meat, in this case, will not necessarily protect you and your family because of a loophole in the Organic Food Act of the United States that allows food animals given genetically modified (GMO) “vaccines” to still be labeled “organic.”

“In light of the fact that the good people at big pharma have worked so hard to create transmissible vaccines that can survive through the food supply we need to ask ourselves whether there are any ulterior motives here,” Renz says.

Learn more about the biotechnological takeover of the food supply at GMO.news.

Sources for this article include:

• TomRenz.substack.com
• ResearchGate.net
• NaturalNews.com

“There’s no issue with flying,” the pilot could be heard saying, “but we need to go back to New York as we can’t resecure the horse.”

Apparently, animals escaping on planes isn’t all that unusual. Last month, an otter and a rat caused mayhem on a flight from Thailand to Taiwan. Earlier this month, a young bear managed to escape on a flight from Baghdad to Dubai.

Animals don’t belong on airplanes. They don’t feel at home high in the sky, it’s unnatural. They have to be heavily sedated to get them through the terrifying experience. I guess they didn’t give those animals enough drugs.

It made me think about what I’m writing today. The governments, corporations and scientists that invest our money (and pay themselves billions of our dollars in the process) to research and experiment on our bodies by altering the very language of life, our DNA, are sure they have everything under control. But what makes them think they can control life and mold it to their will when they don’t even know how it started or the mystery of that spark.

And perhaps one day we ordinary humans will regret giving ourselves over so naively to be analyzed and dissected by these greedy, short-sighted and power-hungry overlords. They promise that their experiments are for our own good, to make us safer, healthier and happier, when their real desire is to extract every bit of information from our DNA in order to create something new and improved—and synthetic.

It was exactly one year ago at the G20 Summit in Indonesia that world leaders signed a “Declaration to Introduce COVID Vaccine Passports”, as well as amendments to its pandemic treaty that would “require swift action by countries and the WHO during an emergency and give the WHO greater powers to act during a crisis”. The plan was to “introduce vaccine passports for their respective jurisdictions, with the stated intention of creating a global verification system to facilitate safe international travel”.

The G20 promised that a Digital Health Certificate using World Health Organization (WHO) standards would be introduced during the next World Health Assembly in Geneva, in May of 2023.

“If you have been vaccinated or tested properly, you can move around. So, for the next pandemic, instead of stopping the movement of people 100%, you can still provide some movement of the people,” Mr. Sadikin said.

What exactly some movement of the people means remains to be seen.

In a statement, the leaders affirmed two goals:

• Their respective countries’ support of the WHO mRNA Vaccine Technology Transfer hub, which aims to build capacity in low- and middle-income countries to produce mRNA vaccines. (I wrote about these hubs in Building the mRNA Empire.)
• Their commitment to a globalized ‘vaccination passport’.

True to their promise one year ago, on June 2, 2023, the WHO announced the launch of a landmark digital health initiative to be rolled out in Europe:

WHO will take up the European Union (EU) system of digital COVID-19 certification to establish a global system that will help facilitate global mobility and protect citizens across the world from on-going and future health threats, including pandemics.

So far, the U.S. doesn’t have a national inoculation database. However, there are many other ways that our DNA is collected, often without our knowledge or permission.

As early as 1990, the FBI began building its treasure trove of DNA. Since then, it has amassed 21.7 million DNA profiles — equivalent to about 7 percent of the U.S. population — according to Bureau data reviewed by The Intercept.

In an April 2023 statement submitted to Congress to explain the FBI’s request to nearly double its current $56.7 million budget, FBI Director Christopher Wray said the FBI collected around 90,000 samples a month — “over 10 times the historical sample volume” — and expected that number to swell to about 120,000 a month, totaling about 1.5 million new DNA samples a year.

What started as a way to monitor violent criminals or sex offenders, is now a way to collect the DNA of any “person of interest”.

But that isn’t all.

Over the years, scientists have been perfecting their methods for collecting DNA and have turned their attention to environmental DNA, or eDNA.

An inexpensive tool for ecologists, eDNA is everywhere — floating in the air, water, snow, food, your last cup of coffee. The eDNA technology is used in wastewater surveillance systems to monitor Covid and other pathogens.

A study demonstrated that scientists could recover medical and ancestry information from minute fragments of human DNA lingering in the environment. DNA of specific individuals can be recovered from spaces such as office buildings, apartment buildings, airports, restaurants.

Recently, researchers descended on the small town of St. Augustine, Florida and, from a “soda-can-size sample of water from a creek”, recovered “enough mitochondrial DNA — passed directly from mother to child for thousands of generations — to generate a snapshot of the genetic ancestry of the population around the creek…. One mitochondrial sample was even complete enough to meet the requirements for the federal missing persons database. They also found key mutations shown to carry a higher risk of diabetes, cardiac issues or several eye diseases”.

Scientists assure us that such eDNA samples will only be used for good by helping to predict pandemics, or uncovering mutations that cause a disease within a community.

Yet, those same eDNA samples could equally be used to find and persecute ethnic minorities or people who are prone to certain illnesses. If you carry it a step further and into the realm of biowarfare, certain groups could purposely be infected with illnesses while the rest of the population would not.

“This gives a powerful new tool to authorities,” said Anna Lewis, a Harvard researcher who studies the ethical, legal and social implications of genetics research. “There’s internationally plenty of reason, I think, to be concerned.”

Countries like China already conduct extensive and explicit genetic tracking of minority populations, including Tibetans and Uighurs. Tools like eDNA analysis could make it that much easier.

Knowing the DNA of an ethnic group means that they could be targeted with biowarfare.

An NIH article Biological Warfare: Infectious Disease and Bioterrorism puts it like this:

Although we rarely perceive it this way, infectious disease is just another manifestation of biological warfare that is ubiquitous throughout life. The evolutionary relationship between hosts and pathogens is essentially a never-ending arms race. When a pathogen evolves a new toxin, the host evolves a response to it. Humanity has taken this arms race one step further by utilizing technology such as vaccines and industrial-scale manufacturing of antibiotics. However, the microbes are fighting back.

Scientists think they can control nature. But they have no idea the long-term consequences of their actions. As humanity’s natural immune system is destroyed by toxic chemicals, drugs, and the very technology that we are promised will save us, experts aren’t suggesting we return to natural remedies and a healthier lifestyle, rather we must ingest more and more of the synthetic drugs perpetuating our illnesses.

Those who get richer and more powerful thanks to the drug and surveillance industries, know very well the dangers this course poses for humanity, yet they keep doing it anyway. It is a way to keep the populace docile and under their control.

Any DNA floating around can be used by authorities to track the populace, to incriminate a person, or to biologically attack them.

Recent developments in synthetic biology—which the National Academy of Sciences defines as “concepts, approaches, and tools which enable the modification or creation of biological organisms”—pose a profound threat. Synthetic bioweapons (SNBWs) can be engineered to target very specific populations or individuals.

Once your DNA leaves your body, it is no longer yours. What are the rules of privacy then? They do not exist. It is a free-for-all.

“Just by breathing, you’re discarding DNA in a way that can be traced back to you,” Lewis said.

If authorities collect your DNA, it doesn’t just affect you, it also affects “family members and, in some contexts, communities,” said Sandra Soo-Jin Lee, a biomedical ethicist at Columbia University.

“DNA tracks to your extended relatives, tracks forward in time to your children, tracks backward in time to your ancestors,” Ms. Murphy added. “In the future, who knows what DNA will tell us about people or how it might be used?”

Which leads us to the CDC’s announcement of its new Traveler-based Genomic Surveillance program.

International travelers arriving at participating airports can volunteer to self-collect nasal swab samples which are then shipped to a laboratory network. Samples that test positive for SARS-CoV-2 undergo whole genome sequencing to determine variants.

However, do not think this is in any way just about Covid. Covid was the excuse to set up a system tracking and monitoring ordinary citizens.

The CDC and Gingko Bioworks are leading the Future of Disease Surveillance:

According to Ginkgo’s press release:

Concentric by Ginkgo, the biosecurity and public health unit of Ginkgo Bioworks, and XpresCheck by XWELL, are partnering to expand their work with the CDC to monitor more than 30 new viruses, bacteria, and antimicrobial resistance targets including several seasonal respiratory pathogens, such as influenza A and B, RSV, and SARS-CoV-2. The partners continue to help the CDC grow TGS’s capabilities to detect pathogens as early as possible, allowing for the best public health response.

The program expansion will launch at four of the program’s seven major international airports (New York, JFK, San Francisco, Boston, and Washington DC, Dulles).

The TGS program has proven to be an agile and beneficial asset to public health officials in the United States—quickly adapting to an evolving pandemic in real time since it launched in 2021. As of October 2023, TGS has enlisted over 370,000 travelers and maintains an ongoing enrollment of around 6,000 volunteer travelers weekly. The program covers travelers from all World Health Organization regions and more than 135 countries. Since its inception, the program has sequenced more than 14,000 samples and made the genomic data available on several public health platforms to enable further analysis. The expansion will enhance the program’s ability to monitor and change focus as needed to identify priority pathogens. The TGS program can augment global surveillance systems, especially as testing and sequencing information become limited as Covid-19 monitoring wanes.

“We thank the volunteers who elect to swab their noses in service to our national security and public health.”
ExpresCheck CEO Ezra Ernst

So, what is GINKGO BIOWORKS?

It’s a one-stop-shop that describes itself as “BIOLOGY BY DESIGN”. You can go on the website and “explore Ginkgo’s capabilities for therapeutics and vaccines, agriculture, nutrition and wellness, and more”.

Since 2015, when Gingko was the first biotech company to be accepted for seed funding by Y Combinator, Ginkgo has raised $429 million, which includes $275 million in funding from Bill Gates’ Cascade Investment and others. Ginkgo is reportedly now worth over $1 billion.

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo’s biosecurity and public health unit, Concentric by Ginkgo, is building global infrastructure for biosecurity to empower governments, communities, and public health leaders to prevent, detect and respond to a wide variety of biological threats.

Here are some of the ways Gingko Bioworks is extending its reach:

• Gingko Bioworks is partnering with Penn State University to “integrate its biosurveillance capabilities into the university’s research of 58 wildlife species for SARS-CoV-2 to monitor potential spillover to humans”.
• It is setting up a BIO4 campus in Serbia, an initiative that has already gathered “more than 1,000 PhD scientists from 17 scientific institutions, and the campus itself will open in 2026. BIO4 brings together the research centers of companies active in biomedicine, biotechnology, bioinformatics and biodiversity. Partnerships have already been signed with AstraZeneca, BGI, Merck, Pfizer, Roche, and more.
• To feed a rapidly growing population on a warming planet, society needs to develop innovative new technologies to grow and distribute food. At Ginkgo, we are working towards a future where genetic engineering can help make foods that are sustainable, healthier, delicious, and accessible to everyone.
• In 2017, Gingko acquired Gen9, where scientists “manipulate DNA” to create “new life forms that do things we tell them to do”. They are “building nanobot factories that will produce microscopic biological machines programmed to make things more efficient and effective”. They are “dissecting organisms and putting them back together to make biological nanobots that perform functions for their creator”.

One of these legendary creators, and a founder of Gen9, is George Church, who in 2018, co-founded Nebula Genomics, a personal genomics company that offers a “whole-genome sequencing service”.

In fact, the company is developing its own blockchain. It claims it will help you “decode all your genes and identify mutations”, “learn about the genetics of your mind”, “use genetic information to extend your life”, and so on. All of this can be yours, in exchange for your “genomic and personal data” so that you can “contribute to future discoveries”.

Yes, everyone wants your data, they are just salivating to get it.

Bill Gates is another one of those creators who is investing big in genomic surveillance and genomic sequencing, along with Gingko, the US CDC and Africa CDC.

Africa Pathogen Genomics Initiative, which launched in 2020 as a joint initiative of the Africa CDC and member states of the African Union.

Dr. David Blazes, Deputy Director on the Gates Foundation’s Global Health team: We’ve really seen this initiative take off in the past year. For example, at the start of 2021 there were about 5,600 sequences of SARS-COV-2 in existence and by the end of 2021, there were over 60,000. The initial plan was to phase-in labs in 20 countries over four years, but the initiative has already expanded to 45 countries.

Short term goals involved Covid, but Covid was just the beginning. As Dr. Blazes explains,

“In the medium-term, we hope that the initiative is able to also address cholera, yellow fever, tuberculosis, and other diseases. Longer term plans include building links between genomic surveillance and local manufacturing of diagnostics, medicines and vaccines. We’ll also be eager to see the types of networks that are built between labs—as well as ministries of health and the Africa CDC.”

How far are we willing to go in giving up our data to the Vast Machine and those who are feeding it. We cannot even breathe without our DNA being collected and analyzed. But don’t worry, it’s all for the greater good, just like George Church assures us.

Prof. George Church’s the Human Genome Project-Write is developing technologies for large-scale engineering of human genomes. Thanks to advancements in synthetic biology, he dreams of reviving the woolly mammoth by inserting mammoth DNA into elephant skin cells which can then be turned into stem cells and used to produce embryos.

This is called “creating the world of tomorrow”.

But it’s not really about making you or me healthier, it’s not really even about bringing woolly mammals back to life, although that’s a great selling point. Once again, all roads lead back to the elites wanting to live forever—and using us as lab rats to do so.

Here’s the scruffy, bearded, elderly Church telling Stephen Colbert how he expects to live forever.

Church excitedly tells Colbert how he’s demonstrated age reversal in animals and Colbert jokingly asks if he cuts a check could he maybe get on the list of folks who will be made younger?

“It’s who you know, that’s how you live forever,” says Colbert.

It’s a joke, but it isn’t really.

Nope, your DNA isn’t being collected at the airport because the government cares about your health and safety and whether or not you have the flu and if you might pass it on to someone else.

It’s all about collecting masses of DNA from the populace, feeding it to the Vast Machine to read and interpret it, using CRISPR to edit it—which I didn’t go into here, but I have in other essays such as Techno Eugenics—so that a new race can be born that will live forever.

No matter which way we turn, all roads seem to lead to this unattainable destination. Just like the horse let loose at 30,000 feet, they aren’t going to be able to put this genie back in the bottle.

About the Author

Karen Hunt [aka KH Mesek] is an author and illustrator of 19 children’s books, the YA series Night Angels Chronicles and the science fiction novel, LUMINARIA: Tales of Earth & Oran, Love & Revenge, to be published in August. She recently returned from living in Luxor, Egypt where she started the first boxing club for girls. Having lived and traveled extensively behind the Iron Curtain, she is devoting her time to writing essays related to the loss of freedom in the West. You can read more of her work, or sign up to her newsletter, here. You can’t follow her twitter any longer, as she’s been banned.

Described by UK officials as a “sharpened tool” in the nation’s continued vaccination campaign, the reformulated vaccine combines the previously approved COVID-19 vaccine with a “vaccine candidate” targeting the Omicron variant BA.1. That vaccine candidate has never been previously approved and has not been the subject of independent study. The MHRA approved the vaccine based on a single, incomplete human trial currently being conducted by Moderna. The company promoted incomplete data from that trial in company press releases in June and July. The study has yet to be published in a medical journal or peer reviewed. No concerns have been raised by any regulatory agency, including the MHRA, regarding Moderna’s past history of engaging in suspect and likely illegal activity in past product trials, including for its original COVID-19 vaccine.

The approval comes shortly before several Western countries, including the UK, plan to conduct a massive COVID-19 booster vaccination campaign this fall. Moderna has also noted that approval for its Omicron booster vaccine are pending in the US, EU, Australia and Canada – all of which are also planning fall vaccination campaigns focused on COVID-19. The company’s CEO, Stéphane Bancel, has called the reformulated vaccine “our lead candidate for a Fall 2022 booster.”

However, unlike the company’s original COVID-19 vaccine, the genetic material, or messenger RNA (mRNA), for this new vaccine, including the newly formulated genetic material meant to provide protection against the Omicron variant, is being manufactured, not by Moderna, but by a relatively new company that has received hardly any media attention, despite its overt links to US intelligence. Last September, it was quietly announced that a company called National Resilience (often referred to simply as Resilience) would begin manufacturing the mRNA for Moderna COVID-19 vaccine products. Under the terms of the multi-year agreement, “Resilience will produce mRNA for the Moderna COVID-19 vaccine at its facility in Mississauga, Ontario, for distribution worldwide.”

“Reinventing Biomanufacturing”

National Resilience was founded relatively recently, in November 2020, and describes itself as “a manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption.” It has since been building “a sustainable network of high-tech, end-to-end manufacturing solutions with the aim to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale.” It furtherplans to “reinvent biomanufacturing” and “democratize access to medicines,” namely gene therapies, experimental vaccines and other “medicines of tomorrow.”

In pursuit of those goals, the company announced it would “actively invest in developing powerful new technologies to manufacture complex medicines that are defining the future of therapeutics, including cell and gene therapies, viral vectors, vaccines, and proteins.” It was founded with the reported intention “to build a better system for manufacturing complex medicines to fight deadly diseases” as a way to improve post-COVID “pandemic preparedness.”

The company initially marketed its manufacturing capabilities as “the Resilience platform”, and offers principally “RNA Modalities”, including RNA development for vaccines, gene editing and therapeutics; and “Virus Production”, including viral vectors, oncolytic viruses (i.e. a virus engineered to preferentially attack cancer cells), viruses for use in vaccine development and gene-edited viruses for unspecified purposes. It is worth noting that, to date, many controversial “gain-of-function” experiments have justified modifying viruses for the same purposes as described by National Resilience’s Virus Production capabilities. In addition, National Resilience offers product formulations and other modalities, such as biologics and cell therapies, to its clientele and the “Virus Production” of its website has since been removed.

National Resilience, being such a young company, has very few clients and there is little publicly available information on its manufacturing capabilities aside from the company’s website. The firm only acquired its first commercial manufacturing plant in March 2021, located in Boston, MA and purchased from Sanofi, followed shortly thereafter by the acquisition of another separate plant located in Mississauga, Ontario, Canada. Makeovers were announced for the plants, but little is publicly known about their progress. Prior to the acquisitions, the company had been subleasing a Bay area facility in Fremont, California. Reporters were puzzled at the time as to why a company with roughly 700 employees at the time had acquired a total of 599,00 square feet of manufacturing space after having only emerged from stealth less than 6 months prior.

In April 2021, National Resilience acquired Ology Bioservices Inc., which had received a $37 million contract from the US military the previous November to develop an advanced anti-COVID-19 monoclonal antibody treatment. This acquisition also provided National Resilience with its first Biosafety Level 3 (BSL-3) laboratory and the ability to manufacture cell and gene therapies, live viral vaccines and vectors and oncolytic viruses.

Despite being in the earliest stages of developing its “revolutionary” manufacturing capabilities, National Resilience entered into a partnership with the Government of Canada in July of last year. Per that agreement, the Canadian government plans to invest CAD 199.2 million (about $154.9 million) into National Resilience’s Ontario-based subsidiary, Resilience Biotechnologies Inc. Most of those funds are destined for use in expanding the Ontario facility that Resilience acquired last March and which is now manufacturing the mRNA for Moderna’s COVID-19 products. Canada’s Minister of Innovation, Science and Industry, François-Philippe Champagne, asserted at the time that the investment would “build future pandemic preparedness” and help “to grow Canada’s life science ecosystem as an engine for our economic recovery.” More recently, in 2022, the company has announced a few new clients – Takeda, Opus Genetics and the US Department of Defense.

According to National Resilience’s executives, the company’s ambitions apparently go far beyond manufacturing RNA and viruses. For instance, Resilience CEO Rahul Singhvi has claimed that the company is seeking to build “the world’s most advanced biopharmaceutical manufacturing ecosystem.” Yet, Singhvi has declined to offer much in the way of specifics when it comes to exactly how the company plans to become the planet’s most elite biomanufacturing company.

In an interview with The San Francisco Business Times, Singhvi states that Resilience is looking to fill its massive manufacturing plants with “technologies and people that can set and apply new standards for manufacturing cell therapies and gene therapies as well as RNA-based treatments.” Prior to Resilience, Singhvi was CEO of NovaVax and an operating partner at Flagship Pioneering, which played a major role in the creation and rise of Moderna.

Singhvi has further insisted that National Resilience is “not a therapeutics company, not a contractor and not a tools company” and instead aims “to boost production using the new therapeutic modalities” such as RNA-based treatments, which have become normalized in the COVID-19 era. Whereas contract manufacturers “are like kitchens, with pots and pans ready for any recipe,” “what we’re trying to do is fix the recipes,” Singhvi has explained. One member of Resilience’s board of directors, former FDA Commissioner and Pfizer Board member Scott Gottlieb, has described the company as seeking to act as the equivalent of Amazon Web Services for the biotechnology industry.

Essentially, Resilience bills itself as offering solutions that will allow “futuristic” medicines, including mRNA vaccines, to be produced more quickly and more efficiently, with the apparent goal of monopolizing certain parts of the biomanufacturing process. It also appears poised to become the manufacturer of choice for mRNA vaccines and experimental therapeutics in the event of a future pandemic, which some public health “philanthropists” like Bill Gates have said is imminent.

Perhaps the company’s most noteworthy ambition relates to their claims that they support clients through the government regulatory process. Given the company’s emphasis on speedy mass production of experimental gene therapies, its stated intention of getting the “futuristic” medical products it manufactures to market as quickly as possible seems at odds with the slower, traditional regulatory processes. Indeed, one could easily argue that the approvals of mRNA vaccines for the first time in human history during the COVID-19 crisis were only possible because of the major relaxing of regulatory procedurse and safety testing due to the perceived urgency of the situation.

Resilience seems intent on seeing that phenomenon repeat itself. As previously mentioned, the company claims to allow for the setting and application of “new standards for manufacturing cell therapies and gene therapies” and also says it plans to become a “technology-aggregating standards bearer that helps therapies come to market more efficiently.” It previously offered on its website “regulatory support” and “strategy consulting” to clients, suggesting that it would seek to mediate between clients and government regulators in order to fulfill its goal of having the products it manufactures taken to market more quickly. In addition, upon launch, the company claimed it planned to obtain unspecified “regulatory capabilities.” If so, it is certainly notable that former top Food and Drug Administration (FDA) officials are either on the company’s board or, as will be noted shortly, played a major role in the company’s creation.

The People Behind Resilience

Resilience was co-founded by Biotech venture capitalist Robert Nelsen, who is known for listening “to science’s earliest whispers, even when data are too early for just about anyone else.” Nelsen was one of the earliest investors in Illumina, a California-based gene-sequencing hardware and software giant that is believed to currently dominate the field of genomics. As mentioned in a previous Unlimited Hangout investigation, Illumina is closely tied to the DARPA-equivalent of the Wellcome Trust known as Wellcome Leap, which is also focused on “futuristic” and transhumanist “medicines.” Nelsen is now chairman of National Resilience’s board, which is a “Who’s Who” of big players from the US National Security State, Big Pharma and Pharma-related “philanthropy.”

However, while Nelsen has been given much of the credit for creating Resilience, he revealed in one interview that the idea for the company had actually come from someone else – Luciana Borio. In July of last year, Nelsen revealed that it was while talking to Borio about “her work running pandemic preparedness on the NSC [National Security Council]” that had “helped lead to the launch of Nelsen’s $800 million biologics manufacturing startup Resilience.”

At the time of their conversation, Borio was the vice president of In-Q-tel, the venture capital arm of the CIA that has been used since its creation in the early 2000s to found a number of companies, many of which act as Agency fronts. Prior to In-Q-Tel, she served as director for medical and biodefense preparedness at the National Security Council during the Trump administration and had previously been the acting chief scientist at the FDA from 2015 to 2017.

Borio is currently a senior fellow for global health at the Council on Foreign Relations, a consultant to Goldman Sachs, a member of the Bill Gates-funded vaccine alliance CEPI, and a partner at Nelsen’s venture capital firm ARCH Venture Partners, which funds Resilience. Nelsen’s ARCH previously funded Nanosys, the company of the controversial scientist Charles Lieber. Around the time of her conversation with Nelsen that led to Resilience’s creation, Borio was co-writing a policy paper for the Johns Hopkins Center for Health Security that recommended linking COVID-19 vaccination status with food stamp programs and rent assistance as a possible means of coercing certain populations to take the experimental vaccine.

Borio is hardly Resilience’s only In-Q-Tel connection, as the CEO of In-Q-Tel, Chris Darby, sits on the company’s board of directors. Darby is also on the board of directors of the CIA Officers Memorial Foundation. Darby was also recently a member of the National Security Commission on Artificial Intelligence (NSCAI), where members of the military, intelligence community and Silicon Valley’s top firms argued for the need to reduce the use of “legacy systems” in favor of AI-focused alternatives as a national security imperative. Among those “legacy systems” identified by the NSCAI were in-person doctor visits and even receiving medical care from a human doctor, as opposed to an AI “doctor.” The NSCAI also argued for the removal of “regulatory barriers” that prevent these new technologies from replacing “legacy systems.”

Another notable board member, in discussing Resilience’s intelligence ties, is Drew Oetting. Oetting works for Cerberus Capital Management, the firm headed by Steve Feinberg who previously led the President’s Intelligence Advisory Board under the Trump administration. Cerberus is notably the parent company of DynCorp, a controversial US national security contractor tied to numerous scandals, including scandals related to sex trafficking in conflict zones. Oetting is also part of the CIA-linked Thorn NGO ostensibly focused on tackling child trafficking that was the subject of a previous Unlimited Hangout investigation.

Oetting is also the co-founder of 8VC, a venture capital firm that is one of the main investors in Resilience. 8VC’s other co-founder is Joe Lonsdale and Oetting “started his career” as Lonsdale’s chief of staff. Lonsdale is the co-founder, alongside Peter Thiel and Alex Karp, of Palantir, a CIA front company and intelligence contractor that is the successor to DARPA’s controversial Total Information Awareness (TIA) mass surveillance and data-mining program. In addition, Oetting previously worked for Bill Gates’ investment fund.

Also worth noting is the presence of Joseph Robert Kerrey, former US Senator for Nebraska and a former member of the conflict-of-interest-ridden 9/11 Commission, on Resilience’s board. Kerrey is currently managing director of Allen & Co., a New York investment banking firm which has hosted an annual “summer camp for billionaires” since 1983. Allen & Co. has long been a major player in networks where organized crime and intelligence intersect, and is mentioned repeatedly throughout my upcoming book One Nation Under Blackmail. For instance, Charles and Herbert Allen, who ran the firm for decades, had considerable business dealings with organized crime kingpins and frontmen for notorious gangsters like Meyer Lansky, particularly in the Bahamas. They were also business partners of Leslie Wexner’s mentors A. Alfred Taubman and Max Fisher as well as associates of Earl Brian, one of the architects of the PROMIS software scandal – which saw organized crime and intelligence networks cooperate to steal and then compromise the PROMIS software for blackmail and clandestine intelligence-gathering purposes. Allen & Co. was a major investor in Brian’s business interests in the technology industry that Brian used in attempts to bankrupt the developers of PROMIS, Inslaw Inc. and to market versions of PROMIS that had been compromised first by Israeli intelligence and, later, the CIA.

In addition to these intelligence-linked individuals, the rest of Resilience’s board includes the former CEO of the Bill & Melinda Gates Foundation, Susan Desmond-Hellmann; former FDA Commissioner and Pfizer board member, Scott Gottlieb; two former executives at Johnson & Johnson; former president and CEO of Teva Pharmaceuticals North American branch, George Barrett; CalTech professor and board member of Alphabet (i.e. Google) and Illumina, Frances Arnold; former executive at Genentech and Merck, Patrick Yang; and Resilience CEO Rahul Singhvi.

To Boost or Not to Boost

It is certainly telling that the normally publicity hungry Moderna has said so little about its partnership with Resilience and that Resilience, despite its ambitious plans, has also avoided the media limelight. Considering Moderna’s history and Resilience’s connections, there may be more to this partnership that meets the eye and concerned members of the public would do well to keep a very close eye on Resilience, its partnerships, and the products it is manufacturing.

Given that we now live in a world where government regulatory decisions on the approval of medicines are increasingly influenced by corporate press releases and normal regulatory procedures have fallen by the wayside for being too “slow,” there is likely to be little scrutiny of the genetic material that Resilience produces for the “medicines of tomorrow.” This seems to be already true for Moderna’s recently retooled COVID-19 vaccine, as there has been no independent examination of the new genetic sequence of mRNA used in the Omicron-specific vaccine candidate or its effects on the human body in the short, medium or long term. For those who are skeptical of the outsized role that intelligence-linked companies are playing in the attempted technological “revolution” in the medical field, it is best to consider Resilience’s role in the upcoming fall vaccination campaign and in future pandemic and public health scenarios before trying its “futuristic” products.

About the Author

Whitney Webb has been a professional writer, researcher and journalist since 2016. She has written for several websites and, from 2017 to 2020, was a staff writer and senior investigative reporter for Mint Press News. She currently writes for The Last American Vagabond.

Article cross-posted from Unlimited Hangout.